IKT NASDAQ
Inhibikase Therapeutics, Inc.
1W: -8.2%
1M: -23.4%
3M: -29.0%
YTD: -19.5%
1Y: +1.9%
3Y: +70.7%
5Y: -86.4%
$1.57
+0.05 (+3.29%)
Weekly Expected Move ±8.0%
$1
$1
$2
$2
$2
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' 15.72.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
10 relationships10
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-06-16
Earliest Filing
2025-02-24
Latest Filing
partner: 9
target: 1
Counterparties (Filed by IKT)
10 relationshipsCompanies named in IKT's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| CorHepta Pharmaceuticals, Inc. | — | target | Target company acquired by Inhibikase Therapeutics, Inc. via a merger agreement. | 2025-02-24 | View |
| Pivot Holding LLC | — | partner | Counterparty in a settlement agreement regarding a prior arbitration dispute. | 2024-10-10 | View |
| Sphaera Pharma Pte. Ltd. | — | partner | Successor entity to which Pivot Holding LLC succeeded in interest regarding a prior collaboration agreement. | 2024-10-10 | View |
| Maxim Group LLC | MMS | partner | Sole placement agent for the Registered Direct Offering | 2024-05-20 | View |
| H.C. Wainwright & Co., LLC | — | partner | Sales agent for the At The Market Offering Agreement | 2024-02-01 | View |
| H.C. Wainwright & Co., LLC | — | partner | Acted as exclusive placement agent for the Registered Direct Offering and Private Placements. | 2023-01-26 | View |
| Piper Sandler & Co. | PIPR | partner | Acted as sales agent for the terminated Equity Distribution Agreement. | 2023-01-26 | View |
| Piper Sandler & Co. | PIPR | partner | Sales agent for the equity distribution agreement | 2022-05-17 | View |
| ThinkEquity | — | partner | Underwriter representative for the public offering of common stock | 2021-06-16 | View |
| Fordham Financial Management, Inc. | — | partner | Parent company of ThinkEquity, the underwriter representative | 2021-06-16 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-20 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-09-08 | Regulation FD; Exhibits | View | |
| 2026-08-26 | Accountant Change; Exhibits | View | |
| 2026-08-11 | Earnings Release; Exhibits | View | |
| 2026-07-29 | Unregistered Equity Sales; Exhibits | View | |
| 2026-07-23 | Regulation FD; Exhibits | View | |
| 2026-07-14 | Other Events; Exhibits | View | |
| 2026-06-29 | Officer/Director Change; Bylaws Amendment; Shareholder Vote; Exhibits | View | |
| 2026-05-12 | Earnings Release; Exhibits | View | |
| 2026-04-07 | Regulation FD; Exhibits | View | |
| 2026-03-26 | Earnings Release; Exhibits | View | |
| 2025-12-19 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-21 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-11-20 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-14 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-06-30 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-14 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-03-27 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR